Berman Capital Advisors’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1K Hold
41
﹤0.01% 1890
2021
Q2
$1K Buy
+41
New +$1.13K ﹤0.01% 1755

Other funds holding IRMD

Berman Capital Advisors's IRMD Position: Q3 2021 in Review

Berman Capital Advisors held its iRadimed (IRMD) position steady in Q3 2021 at 41 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1890.

Berman Capital Advisors first reported a position in IRMD in Q2 2021 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold IRMD as of Q3 2021.

  • Berman Capital Advisors held 41 shares of iRadimed worth $1K as of Q3 2021.
  • Berman Capital Advisors left its iRadimed share count unchanged in Q3 2021.
  • iRadimed made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1890 holding.
  • Berman Capital Advisors first reported a position in iRadimed in Q2 2021 and has held it in 2 quarters since.
  • 74 funds tracked by Wall St. Rank held iRadimed as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.